ARTRYA Ltd

AYA · AU · Healthcare / Health Information Services

3.19AUD-0.25 (-7.27%)

Price History

Full chart

Market Stats

Previous Close3.44

Open3.50

Day Range3.15 – 3.77

52-Week Range2.36 – 6.49

Volume1.56M

Market Cap606.21M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.17

Dividend Yield0.00%

Beta0.59

50-Day Avg4.21

200-Day Avg4.25

About

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. It offers Salix, a suite of cloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. The company was incorporated in 2018 and is based in West Perth, Australia.

Company Details

SectorHealthcare
IndustryHealth Information Services
CEOMr. John Konstantopoulos B.E.
Employees0
Headquarters1257 Hay Street, West Perth, WA, Australia, 6005, Australia
Websitehttps://www.artrya.com

Leadership

Mr. Bernard William Ridgeway F.A.C.I.D.Executive Chair · b. 1953
Mr. John Konstantopoulos B.E.Co-Founder & CEO
Mr. Clayton James Hatch B.Comm, CPAChief Financial Officer
Phil BowenChief Operations Officer
Prof. Girish Dwivedi M.D.Chief Scientific Officer
Dr. Richard M. StewartChief Regulatory Affairs & Quality Officer
Ryan AthearnHead of Global Clinical Operations
Mr. Mark Edward Pitts F.C.A.Company Secretary · b. 1962

Financials

Income Statement

Currency: AUD	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Revenue	0	0	0	0	0	0	28.00K	28.00K
Growth (%)	-	-	-	-	-	-	-	0.00%
Cost of Revenue	90	11.54K	38.51K	202.00K	552.00K	13.25M	16.02M	1.25M
Gross Profit	-90	-11.54K	-38.51K	-202.00K	-552.00K	-13.25M	-15.99M	-1.23M
Gross Margin	-	-	-	-	-	-	-57103.57%	-4382.14%
Operating Expense	145.57K	1.74M	4.20M	14.52M	11.87M	1.15M	629.00K	26.07M
Operating Income	-145.66K	-1.76M	-4.24M	-14.72M	-12.42M	-14.40M	-16.62M	-27.29M
Operating Margin	-	-	-	-	-	-	-59350.00%	-97478.57%
EBITDA	-145.57K	-1.34M	-4.01M	-16.40M	-10.51M	-13.96M	-16.21M	-26.04M
EBITDA Margin	-	-	-	-	-	-	-57900.00%	-92996.43%
Net Income	-145.67K	-1.35M	-4.08M	-17.16M	-11.14M	-14.00M	-16.41M	-25.18M
Net Income Margin	-	-	-	-	-	-	-58592.85%	-89939.29%
R&D	-	-	-	-	-	1.44M	638.00K	-
R&D as % of Total Revenue	-	-	-	-	-	-	2278.57%	-
Interest Expense	10	6.60K	26.75K	7.00K	58.00K	31.00K	29.00K	16.00K
Interest Expense % of Total Revenue	-	-	-	-	-	-	103.57%	57.14%

Balance Sheet

Currency: AUD	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Assets	914.54K	2.66M	52.22M	43.87M	33.09M	19.01M	23.68M	85.35M
Total Liabilities	61.57K	162.39K	1.17M	3.23M	2.53M	2.21M	2.39M	7.06M
Total Equity	852.97K	2.49M	51.05M	40.64M	30.56M	16.80M	21.29M	78.29M
Cash	910.08K	2.23M	50.13M	15.29M	20.28M	7.13M	11.33M	44.17M
Total Debt	10.49K	10.62K	47.00K	1.37M	1.21M	949.00K	624.00K	247.00K
Net Debt	-899.59K	-2.22M	-50.08M	-13.92M	-19.07M	-6.18M	-10.71M	-43.93M

Cash Flow

Currency: AUD	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Operating Cash Flow	-95.94K	-1.62M	-1.49M	-9.61M	-10.74M	-15.41M	-14.27M	-15.77M
Investing Cash Flow	-3.04K	-15.48K	-1.86M	-26.59M	16.27M	2.71M	7.00K	-30.50M
Financing Cash Flow	1.01M	2.96M	14.10M	38.53M	-245.00K	-299.00K	18.46M	79.00M
Capital Expenditure	3.04K	15.48K	2.06M	6.38M	5.95M	46.00K	263.00K	140.00K
Free Cash Flow	-98.99K	-1.64M	-3.55M	-15.99M	-16.69M	-15.41M	-14.53M	-15.91M
Dividends Paid	-	-	-	107	-	-	-	-
FCF to OCF	103.17%	100.95%	238.84%	166.42%	155.41%	100.00%	101.84%	100.89%
Dividend Paid to FCF	-	-	-	-0.00%	-	-	-	-

Earnings

Report Date	Feb 20, 2022	Aug 31, 2022	Feb 21, 2023	Feb 24, 2025	Aug 20, 2025
EPS Estimate	0.00	0.00	-	0.00	0.00
EPS Actual	-0.08	-0.19	-0.08	-0.09	-0.09
Surprise	-	-	-	-	-
Timing	-	After-hours	After-hours	-	-

Key Statistics & Ratios

Market Cap606.21M

Enterprise Value519.26M

Trailing P/E0.00

Forward P/E0.00

PEG Ratio0.00

Price / Sales21650.43

Price / Book7.62

EPS-0.17

Book Value0.48

Revenue (TTM)28.00K

Gross Profit (TTM)-20.02M

EBITDA-27.13M

Profit Margin0.00%

Operating Margin-114328.56%

Return on Equity-50.58%

Return on Assets-31.64%

Shares Outstanding163.84M

Shares Float117.34M

Beta0.59

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%